Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?

Current therapies for treating Glioblastoma (GB), and brain tumours in general, are inefficient and represent numerous challenges. In addition to surgical resection, chemotherapy and radiotherapy are presently used as standards of care. However, treated patients still face a dismal prognosis with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfonso-Triguero, Paula, Lorenzo, Julia, Candiota, Ana Paula, Arús, Carles, Ruiz-Molina, Daniel, Novio, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223043/
https://www.ncbi.nlm.nih.gov/pubmed/37242036
http://dx.doi.org/10.3390/nano13101619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223043/
https://www.ncbi.nlm.nih.gov/pubmed/37242036
http://dx.doi.org/10.3390/nano13101619

Ejemplares similares